Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences:

  • B. Riley FBR Healthcare Conference
    Tuesday, September 4, 2018 (one-on-one meetings only)
    Location: New York, NY

  • Wells Fargo Healthcare Conference
    Wednesday, September 5, 2018 at 1:50 p.m. ET*
    Location: Boston, MA

  • Morgan Stanley Global Healthcare Conference
    Thursday, September 13, 2018 at 4:05 p.m. ET*
    Location: New York, NY

  • Oppenheimer Fall Summit
    Thursday, September 27, 2018 (one-on-one meetings only)
    Location: New York, NY

  • Cantor Fitzgerald Global Healthcare Conference
    Tuesday, October 2, 2018 at 8:00 a.m. ET*
    Location: New York, NY

*To access the live webcast, please visit the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast and a copy of the slide presentation will be archived on the site for 30 days.

About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. In addition, AMAG seeks to collaborate on and acquire promising therapies at various stages of development, and advance them through the clinical and regulatory process to deliver new treatment options to patients. For additional company information, please visit www.amagpharma.com.

Contact:
Linda Lennox
908-627-3424

Primary Logo

AMAG Pharmaceuticals, Inc.